New DNA Tech Unlocks Male Infertility Secrets

A recent comprehensive study in India, conducted by the FRIGE Institute of Human Genetics and ICMR, has shed light on the genetic underpinnings of male infertility. Analyzing 247 men between 2021 and 2024, the research employed advanced DNA sequencing technologies, including targeted sequencing and whole exome sequencing. These methods significantly improved diagnostic yield, identifying genetic causes in approximately 1 in 13 men, and estimating that one in eight to one in five infertile men may have an underlying genetic basis for their condition.

The study highlighted that many common male infertility genes operate through recessive inheritance, a factor particularly relevant in India due to community marriages. Traditional genetic tests like chromosome analysis detected abnormalities in only a small fraction of cases. However, the newer DNA sequencing approaches can pinpoint specific gene mutations, such as those in CFTR, which can lead to blocked sperm ducts, a condition often missed without genetic testing.

This genetic clarity is crucial for couples facing infertility. Early diagnosis allows for more effective planning of sperm retrieval and IVF procedures. It also enables assessment of risks for cystic fibrosis in future children and male relatives, facilitating informed genetic counseling and family planning. The study also showcased an India-developed patented technology for targeted sequencing, promising more efficient and cost-effective diagnostic strategies.